Lyme disease can affect your liver, and it does so more often than most people realize. Studies of patients with early Lyme disease have found that roughly 27 to 40 percent show at least one abnormal liver test result, even when they feel fine aside from the telltale rash. The good news is that these liver changes are almost always mild and tend to clear up with standard antibiotic treatment. Severe liver complications from Lyme disease exist but are genuinely rare, and sorting out what is actually causing the problem requires some careful detective work.
How Often Lyme Disease Shows Up on Liver Tests
Two well-known studies put numbers on this. One evaluated 115 patients diagnosed with erythema migrans, the expanding bull’s-eye rash that marks early Lyme disease, and found that 40 percent had at least one abnormal liver test. Twenty-seven percent had more than one abnormal result, compared to just 4 percent in a healthy control group. The liver enzymes most commonly out of range were gamma-glutamyl transpeptidase (GGT) at 28 percent and alanine transaminase (ALT) at 27 percent.1PubMed. Liver function in early Lyme disease A separate study of 73 patients with early Lyme disease reported a similar figure: 27 percent had liver function abnormalities, with GGT elevation again being the most common.2PubMed. Liver function test abnormalities in early Lyme disease
These numbers are high enough to matter clinically, but context is important. “Abnormal liver test” does not mean the liver is failing or even obviously sick. In most of these patients, the elevations were modest, and the patients themselves had no symptoms pointing to the liver at all. If your doctor had not run blood work, you would not have known anything was going on. This is one reason liver involvement in Lyme disease flew under the radar for a long time and still surprises some physicians who associate the infection primarily with joint pain, neurological problems, and heart issues.
How far the infection has spread in your body matters. Patients with early disseminated Lyme disease, meaning the bacteria had moved beyond the initial bite site and were causing symptoms in multiple areas, were roughly twice as likely to have abnormal liver tests (66 percent) compared with patients whose disease was still localized around the rash (34 percent).1PubMed. Liver function in early Lyme disease This makes intuitive sense. Once the Lyme spirochete, Borrelia burgdorferi, enters the bloodstream and starts seeding different organs, the liver is one of many tissues that can become inflamed.
What the Liver Changes Actually Look Like
For the vast majority of people, Lyme-related liver effects fall squarely in the “subclinical” category. Your blood tests show enzyme levels that are higher than normal, but you do not feel sick from it, your liver is functioning fine in every practical sense, and the numbers drift back to normal on their own once the infection is treated. After antibiotic therapy, elevated liver tests improved or resolved in most patients within about three weeks of starting treatment.1PubMed. Liver function in early Lyme disease
The pattern of which enzymes are elevated can help doctors figure out what is going on. In Lyme hepatitis, the most commonly elevated markers are GGT and ALT. GGT is associated with bile duct irritation and general liver stress, while ALT is a marker of liver cell damage. This combination suggests a mixed picture: some degree of inflammation in the liver tissue itself (hepatitis in the clinical sense, meaning liver inflammation), along with some irritation of the bile-processing pathways. Bilirubin, the yellow pigment that causes jaundice when it builds up, is almost never elevated in early Lyme disease. In one study, abnormal bilirubin showed up in only 3 out of 115 patients.3PubMed Central. Severe Hyperbilirubinemia: A Rare Complication of Lyme Disease
Gastrointestinal complaints like nausea, loss of appetite, and mild abdominal discomfort do show up in early Lyme disease with some regularity. Whether those symptoms come directly from liver inflammation or from the systemic infection itself is hard to tease apart. For most patients, these complaints are part of the general flu-like feeling that accompanies early Lyme and are not specifically liver-driven.
Rare but Real Severe Liver Complications
While the typical pattern is mild and self-limiting, there are scattered case reports of Lyme disease causing serious liver problems. Severe hyperbilirubinemia, where bilirubin levels spike high enough to cause visible jaundice, has been described in only a handful of published cases. One report detailed a 39-year-old man who came to the emergency room with febrile jaundice, diffuse joint pain, and scleral icterus (yellowing of the whites of the eyes), with lab work showing severe hyperbilirubinemia.4PubMed Central. Lyme Disease and Severe Hyperbilirubinemia: A Rare Presentation of Lyme Disease Another case report described severe hyperbilirubinemia as the presenting symptom that led to a Lyme diagnosis, noting that only two prior reports in the entire medical literature had attributed this finding to Lyme disease.3PubMed Central. Severe Hyperbilirubinemia: A Rare Complication of Lyme Disease
Acute liver failure from Lyme disease alone has essentially not been documented. One case report examining a fatal outcome involving fulminant liver failure found that the patient was co-infected with both Babesia microti and Borrelia burgdorferi, and the authors noted that Lyme disease on its own is typically associated with mild, transient liver enzyme elevations and has not been linked to acute liver failure.5PubMed Central. A lethal combination: fulminant liver failure due to Babesia microti and Borrelia burgdorferi co-infection So while it is theoretically possible for Lyme to cause significant liver damage, the medical literature strongly suggests that if someone with Lyme disease develops serious liver failure, something else is going on too.
Coinfections That Hit the Liver Harder
This is where the picture gets genuinely complicated. The same ticks that carry Borrelia burgdorferi often carry other pathogens, and some of those are far more aggressive when it comes to the liver. The two most clinically relevant coinfections are anaplasmosis (caused by Anaplasma phagocytophilum) and babesiosis (caused by Babesia microti).
Anaplasmosis, sometimes called human granulocytic anaplasmosis, classically produces high fever, low white blood cell counts, low platelets, and elevated liver enzymes. When a patient shows up with the Lyme rash but also has fever, dropping blood counts, and liver tests that are more abnormal than you would expect from Lyme alone, coinfection with Anaplasma is something doctors need to consider.6Emerging Infectious Diseases. Borrelia burgdorferi and Anaplasma phagocytophilum Coinfection In severe cases, anaplasmosis can cause significant liver cell damage alongside kidney injury and extremely elevated ferritin levels.7PubMed Central. Severe Human Granulocytic Anaplasmosis With Significantly Elevated Ferritin Levels in an Immunocompetent Host in Pennsylvania
Babesiosis affects the liver through a different mechanism. Babesia parasites invade red blood cells and destroy them, leading to hemolytic anemia. The resulting flood of hemoglobin breakdown products can overwhelm the liver’s ability to process bilirubin, causing jaundice and sometimes liver failure in severe cases. When Babesia and Borrelia are both present, the combined assault can be far worse than either infection alone. The case of fatal fulminant liver failure mentioned earlier involved exactly this scenario: a dual infection where the combination created a cascade of organ damage that neither pathogen would have caused individually.5PubMed Central. A lethal combination: fulminant liver failure due to Babesia microti and Borrelia burgdorferi co-infection
The practical takeaway here is that if you have been diagnosed with Lyme disease and your liver tests are significantly elevated, or if you have high fevers and abnormal blood counts that seem out of proportion for Lyme alone, your doctor should test for coinfections. This is especially true in areas where blacklegged ticks carry multiple pathogens, which includes much of the northeastern United States and parts of the upper Midwest.
Telling Lyme Hepatitis Apart From Other Causes
Abnormal liver tests with a rash present a diagnostic puzzle, because the list of things that can cause both is long. Clinicians need to consider syphilitic hepatitis (which also involves a spirochete and can cause a rash alongside liver inflammation), chronic liver disease with its own skin findings, and drug-induced liver injury, among other possibilities.8PubMed Central. Prime Time or Lyme Time: A Case of Lyme Hepatitis in the Emergency Department
The diagnostic process typically involves ruling out the more common culprits before attributing liver enzyme elevations to Lyme. In studies of Lyme-related liver involvement, researchers systematically excluded hepatitis A, B, and C as causes of the abnormal results.1PubMed. Liver function in early Lyme disease This matters in real clinical practice because many patients with Lyme disease are initially undiagnosed or misdiagnosed. A person who walks into a clinic with fatigue, mild nausea, and abnormal liver enzymes might get worked up for viral hepatitis, autoimmune liver disease, or alcohol-related damage before anyone considers a tick-borne infection, especially if the classic bull’s-eye rash is absent or went unnoticed.
The timing and pattern of enzyme elevations can offer clues. In Lyme hepatitis, the abnormalities tend to appear alongside or shortly after the onset of other early Lyme symptoms. They are typically moderate rather than dramatic, and they involve the specific combination of GGT and ALT elevation with normal or near-normal bilirubin. A pattern of extremely high bilirubin or markedly elevated alkaline phosphatase would push the differential toward other diagnoses. Geographic context and tick exposure history are also critical. In endemic areas during tick season, a rash combined with liver test abnormalities should prompt Lyme testing even if the rash does not look like the textbook bull’s-eye pattern.
When the Lyme Treatment Itself Hurts the Liver
Here is an underappreciated wrinkle: the antibiotics used to treat Lyme disease can sometimes cause liver injury on their own. Doxycycline, the first-line treatment for most cases of Lyme disease, is generally well tolerated, but drug-induced liver injury from doxycycline does occur. One case report described a healthy 28-year-old man who developed nausea, vomiting, fatigue, and significant liver enzyme elevations in a hepatocellular pattern after just five days of doxycycline therapy for Lyme disease. A thorough workup excluded infection, autoimmune disease, malignancy, and metabolic disorders, and the liver injury was attributed to the doxycycline itself.9PubMed Central. Drug-Induced Liver Injury Due to Doxycycline: A Case Report and Review of Literature
This creates a diagnostic headache. If you are being treated for Lyme disease and your liver tests are abnormal, is it the Lyme infection, the antibiotic, or both? In most cases, the timeline helps clarify things. Lyme-related enzyme elevations tend to be present before treatment starts or very early in the course, and they improve as the antibiotics clear the infection. Drug-induced liver injury from doxycycline usually appears a few days into treatment and worsens while the drug is continued. If your liver tests were normal at diagnosis and then climbed during treatment, or if they were abnormal and got worse instead of better, drug-induced injury becomes a real consideration.
For most patients, this is not something to worry about. Doxycycline-related liver injury is uncommon, and the vast majority of people complete their course of antibiotics without any liver issues. But if you are experiencing new nausea, abdominal discomfort, or unusual fatigue that starts after beginning your antibiotic course, it is worth flagging for your doctor.
People With Pre-existing Liver Conditions
A question that comes up naturally is whether having an underlying liver condition, such as fatty liver disease, hepatitis C, or cirrhosis, makes Lyme-related liver involvement worse. There is no large body of research addressing this specific intersection. What we can reason from the existing evidence is that Lyme disease adds a mild inflammatory insult to the liver, and a liver that is already compromised would logically be less equipped to handle that additional stress. The enzyme elevations that are clinically meaningless in someone with a healthy liver might push someone with advanced liver disease closer to a symptomatic threshold.
The doxycycline question also becomes more pressing for people with liver disease. While doxycycline is not considered a major liver-toxic drug, it is metabolized partially through hepatic pathways, and clinicians may monitor liver function more closely during treatment in patients who already have baseline liver abnormalities. If you have a known liver condition and develop Lyme disease, your doctor will likely want to check your liver tests before starting antibiotics and then recheck them during treatment to ensure the numbers are heading in the right direction.
Alcohol use is another factor. Alcohol and Lyme disease each independently raise GGT levels, so in a patient who drinks regularly, it can be hard to know which factor is driving the elevation. Reducing or eliminating alcohol during Lyme treatment is probably sensible both for this diagnostic reason and because the liver is dealing with enough already between the infection and the antibiotic.
Why Lyme Hepatitis Flies Under the Radar
Given that somewhere around a quarter to 40 percent of patients with early Lyme disease have abnormal liver tests, it is striking how rarely this gets discussed in patient-facing materials about the disease. Part of the reason is that the liver involvement is clinically silent in most cases. The abnormalities resolve with treatment, they rarely cause symptoms, and they almost never progress to anything dangerous. For the physician managing a case of early Lyme disease, the liver is simply not where the clinical drama is happening. The expanding rash, the potential for cardiac conduction abnormalities, the risk of neurological involvement, and the possibility of chronic joint inflammation all command more attention.
But knowing about liver involvement matters for at least a couple of practical reasons. First, if you are diagnosed with Lyme disease and your blood work shows elevated liver enzymes, you should not panic or assume you have a separate liver problem. Second, and more importantly, the reverse can happen: if you show up at a doctor’s office with unexplained liver enzyme elevations and you live in or have recently visited a Lyme-endemic area, tick-borne infection should be on the list of possibilities, even if you do not recall a tick bite or a rash. Up to 30 percent of people with confirmed Lyme disease never notice the erythema migrans rash, which means the classic visual cue that would point a doctor toward the right diagnosis might be missing entirely.
Lyme Hepatitis in Children
Children are among the most commonly affected groups for Lyme disease overall, with the highest incidence in the 5-to-15-year-old age range. Pediatric cases of Lyme hepatitis follow a similar pattern to adults: mild, often asymptomatic liver enzyme elevations that resolve with treatment. However, because children are more likely to present with nonspecific symptoms like fatigue, headache, and poor appetite, and because parents may not notice or report a tick bite, the combination of these symptoms with unexplained liver enzyme abnormalities can initially lead clinicians down the wrong diagnostic path. In pediatric patients presenting with elevated liver enzymes and a recent history of outdoor activity in a tick-endemic area, Lyme disease belongs on the differential even in the absence of a rash.
One clinical scenario that occasionally arises in children is the discovery of abnormal liver tests during a routine workup for what seems like a viral illness. The child has a fever, feels generally unwell, and blood work comes back showing mildly elevated transaminases. Viral hepatitis is tested for and comes back negative, and the next step might be imaging or further blood work looking for rare metabolic conditions. Adding Lyme serology to the initial panel in endemic areas can sometimes shortcut this process and avoid unnecessary testing.
Monitoring After Treatment
For most patients with uncomplicated Lyme disease, formal liver monitoring after treatment is not routinely recommended. The evidence suggests that liver enzyme abnormalities resolve within weeks of starting appropriate antibiotics, and in practice, most patients feel well enough after completing their course that follow-up blood work is dictated by symptoms rather than protocol. If you had markedly abnormal liver tests at diagnosis, your doctor might check them again a few weeks after finishing treatment just to confirm they have normalized.
Patients whose liver tests do not improve or who develop new liver symptoms after completing treatment deserve a closer look. Persistent enzyme elevations after successful Lyme treatment might suggest a coinfection that was not initially identified, drug-induced liver injury that is still resolving, or an unrelated liver condition that was incidentally uncovered during the Lyme workup. This last possibility is not uncommon: nonalcoholic fatty liver disease is present in roughly a quarter of the adult population in the United States, and many people are unaware of it until blood work for some other reason reveals elevated enzymes. A Lyme diagnosis sometimes becomes the occasion for discovering a completely separate liver issue that has been quietly present all along.